44
Participants
Start Date
July 31, 2014
Primary Completion Date
November 30, 2018
Study Completion Date
November 30, 2018
Letrozole
Afatinib
Hospital de Especialidades de Jerez de La Frontera, Jerez de la Frontera
Complexo Hospitalario Universitario A Coruña, A Coruña
Hope Women's Cancer Centers, Asheville
Hospital Clínico Universitario Virgen de La Arrixaca, Murcia
Orlando Health, Inc., Orlando
Hospital Universitari de Sant Joan de Reus, Reus
Hospital Universitario Miguel Servet, Zaragoza
Clinical Center of University in Sarajevo, Clinic for Oncology, Sarajevo
University Clinical Center Tuzla Clinic for Oncology, Hematology and Radiotherapy, Tuzla
University Hospital Clinical Center Banja Luka, Oncology Clinic, Banja Luka
Comprehensive Cancer Centers of Nevada, Las Vegas
University of California Los Angeles Hematology Oncology, Los Angeles
DBA Torrance Memorial Physician Network/Cancer Care Associates, Redondo Beach
West Valley Hematology Oncology Medical Group, Northridge
St. Jude Heritage Healthcare, Fullerton
Coastal Integrative Cancer Care, San Luis Obispo
Central Coast Medical Oncology Corporation, Santa Maria
County Hospital Ploiesti, Ploieşti
County Emergency Clinical Hospital Cluj-Napoca Oncology Department, Cluj-Napoca
SC Medisprof SRL, Cluj-Napoca
"County Emergency Hospital Sf Ioan cel Nou", Suceava
Filantropia Clinical Hospital, Bucharest
Oncomed SRL Timisoara, Timișoara
Complejo Hospitalario Universitario de Albacete, Albacete
Hospital General Universitario de Alicante, Alicante
Hospital Son Llatzer, Palma de Mallorca
Collaborators (1)
Boehringer Ingelheim
INDUSTRY
Translational Research in Oncology
OTHER